Pfizer eyes $34b in COVID-19 sales in 2021, sees demand lasting for years

Pfizer eyes $34b in COVID-19 sales in 2021, sees demand lasting for years

Sydney Morning Herald

Published

Pfizer laid out a plan to turn its vaccine into a long-term business as chief executive officer Albert Bourla bets COVID-19 will become endemic, requiring people to get regular shots for years to come.

Full Article